BANANAS
October 15, 2026 Bonus Content: Merck, AbbVie, and Pfizer All Gained 4% Yesterday. How to Own the Rotation Without Chasing…
October 15, 2026 Bonus Content: Merck, AbbVie, and Pfizer All Gained 4% Yesterday. How to Own the Rotation Without Chasing…
Ukraine’s Starlink limits exposed a risk SPCX and TSLA investors should weigh.
October 15, 2026 Bonus Content: Nvidia Still Leads China’s AI Chip Market. The Gap Is Closing. A note from our…
October 14, 2026 The ZO Skin Health deal shows where durable consumer spending is hiding, and which public companies sit…
David Solomon used the Q3 earnings call to shut down succession rumors, days after $500 million in executive stock awards.
October 14, 2026 Bonus Content: Nvidia Is Pouring $10 Billion Into Europe. What It Says About Demand. A note from…
A $3 billion ad business, a new Disney licensing deal, and a stock near its July low set the stage for next week.
October 13, 2026 Bonus Content: The Valve Suppliers Quietly Winning the sCO2 Boom A note from our friends at Paradigm…
Microfluidic diagnostics are compressing hospital-grade testing into benchtop devices. The acquisition math already tells you who is winning.
October 13, 2026 The $2.4 billion headline obscures a wide gap between firms with large commitments and those offering modest…